Karl Riabowol

10.2k total citations · 1 hit paper
141 papers, 8.1k citations indexed

About

Karl Riabowol is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Karl Riabowol has authored 141 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Molecular Biology, 31 papers in Physiology and 22 papers in Oncology. Recurrent topics in Karl Riabowol's work include Epigenetics and DNA Methylation (45 papers), Telomeres, Telomerase, and Senescence (29 papers) and Genomics and Chromatin Dynamics (27 papers). Karl Riabowol is often cited by papers focused on Epigenetics and DNA Methylation (45 papers), Telomeres, Telomerase, and Senescence (29 papers) and Genomics and Chromatin Dynamics (27 papers). Karl Riabowol collaborates with scholars based in Canada, United States and Japan. Karl Riabowol's co-authors include Igor Garkavtsev, Lee Mizzen, William J. Welch, Hubert Wong, Michael Gilman, Peter Atadja, Asuka Suzuki, William D. Anderson, Ting Cheng and James R. Feramisco and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Karl Riabowol

137 papers receiving 8.0k citations

Hit Papers

Heat Shock Is Lethal to F... 1988 2026 2000 2013 1988 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl Riabowol Canada 47 6.3k 1.8k 1.4k 860 780 141 8.1k
Shomit Sengupta United States 13 4.6k 0.7× 1.4k 0.7× 925 0.7× 705 0.8× 621 0.8× 16 6.5k
José M.P. Freije Spain 47 6.1k 1.0× 1.6k 0.9× 1.1k 0.8× 2.1k 2.5× 571 0.7× 98 9.2k
Stephan Wullschleger Switzerland 21 6.3k 1.0× 1.3k 0.7× 703 0.5× 871 1.0× 950 1.2× 26 8.8k
Diane C. Fingar United States 33 6.2k 1.0× 932 0.5× 1.2k 0.9× 731 0.8× 949 1.2× 49 8.7k
Josée N. Lavoie Canada 29 5.1k 0.8× 1.0k 0.5× 626 0.5× 439 0.5× 1.3k 1.7× 63 6.3k
Andrew D Sharrocks United Kingdom 48 7.3k 1.2× 1.7k 0.9× 487 0.4× 1.3k 1.5× 801 1.0× 106 9.2k
Zuzana Tóthová United States 23 6.5k 1.0× 929 0.5× 703 0.5× 700 0.8× 372 0.5× 47 8.4k
Zhen‐Qiang Pan United States 38 6.4k 1.0× 1.4k 0.8× 1.1k 0.8× 653 0.8× 1.2k 1.5× 68 7.4k
Clayton R. Hunt United States 38 4.6k 0.7× 666 0.4× 816 0.6× 460 0.5× 694 0.9× 95 6.0k
Alejo Efeyan Spain 24 6.0k 1.0× 1.4k 0.8× 1.9k 1.4× 1.1k 1.2× 1.3k 1.7× 49 9.5k

Countries citing papers authored by Karl Riabowol

Since Specialization
Citations

This map shows the geographic impact of Karl Riabowol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Riabowol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Riabowol more than expected).

Fields of papers citing papers by Karl Riabowol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Riabowol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Riabowol. The network helps show where Karl Riabowol may publish in the future.

Co-authorship network of co-authors of Karl Riabowol

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Riabowol. A scholar is included among the top collaborators of Karl Riabowol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Riabowol. Karl Riabowol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahé, Etienne, Tak‐Ho Chu, Yang Yang, et al.. (2025). Knockout of the ING5 epigenetic regulator confirms roles in stem cell maintenance and tumor suppression in vivo. PLoS ONE. 20(1). e0313255–e0313255. 2 indexed citations
2.
Riabowol, Karl, et al.. (2025). L-asparaginase is a PAR2 N-terminal protease that unmasks the PAR2 tethered ligand. Cell Death Discovery. 11(1). 152–152.
3.
Riabowol, Karl, et al.. (2020). Senolytics: A Translational Bridge Between Cellular Senescence and Organismal Aging. Frontiers in Cell and Developmental Biology. 7. 367–367. 43 indexed citations
4.
Fink, Dieter, Arash Nabbi, Bettina Wagner, et al.. (2019). Loss of Ing3 Expression Results in Growth Retardation and Embryonic Death. Cancers. 12(1). 80–80. 15 indexed citations
5.
Thalappilly, Subhash, et al.. (2013). ING1b-inducible microRNA203 inhibits cell proliferation. British Journal of Cancer. 108(5). 1143–1148. 17 indexed citations
6.
Bose, Pinaki, Satbir Thakur, Subhash Thalappilly, et al.. (2013). ING1 induces apoptosis through direct effects at the mitochondria. Cell Death and Disease. 4(9). e788–e788. 31 indexed citations
7.
Netherton, Stuart J., Krishna Pada Sarker, Lili Deng, et al.. (2012). Identification of a Novel Function for the Chromatin Remodeling Protein ING2 in Muscle Differentiation. PLoS ONE. 7(7). e40684–e40684. 19 indexed citations
8.
Suzuki, Asuka, et al.. (2011). Domain Recognition of the ING1 Tumor Suppressor by a Panel of Monoclonal Antibodies. Hybridoma. 30(3). 239–245. 10 indexed citations
9.
Thalappilly, Subhash, Xiaolan Feng, Asuka Suzuki, et al.. (2011). The p53 Tumor Suppressor Is Stabilized by Inhibitor of Growth 1 (ING1) by Blocking Polyubiquitination. PLoS ONE. 6(6). e21065–e21065. 35 indexed citations
10.
Russell, Michael W., Mohamed A. Soliman, David C. Schriemer, & Karl Riabowol. (2008). ING1 protein targeting to the nucleus by karyopherins is necessary for activation of p21. Biochemical and Biophysical Research Communications. 374(3). 490–495. 18 indexed citations
11.
Han, Xijing, Philip Berardi, & Karl Riabowol. (2006). Chromatin Modification and Senescence: Linkage by Tumor Suppressors?. Rejuvenation Research. 9(1). 69–76. 15 indexed citations
12.
Gong, Wei, Michael W. Russell, Asuka Suzuki, & Karl Riabowol. (2006). Subcellular Targeting of p33 ING1b by Phosphorylation-Dependent 14-3-3 Binding Regulates p21 WAF1 Expression. Molecular and Cellular Biology. 26(8). 2947–2954. 48 indexed citations
13.
Cook, Linda S., et al.. (2005). Paternal age is positively linked to telomere length of children. Aging Cell. 4(2). 97–101. 175 indexed citations
14.
Berardi, Philip, Michael W. Russell, Assam El‐Osta, & Karl Riabowol. (2004). DNA damage repair and transcription. Cellular and Molecular Life Sciences. 61(17). 2173–80. 23 indexed citations
15.
Toyama, Tatsuya, Hirotaka Iwase, Hiroko Yamashita, et al.. (2003). p33ING1b stimulates the transcriptional activity of the estrogen receptor α via its activation function (AF) 2 domain. The Journal of Steroid Biochemistry and Molecular Biology. 87(1). 57–63. 15 indexed citations
16.
Vieyra, Diego, Robbie Loewith, Michelle S. Scott, et al.. (2002). Human ING1 Proteins Differentially Regulate Histone Acetylation. Journal of Biological Chemistry. 277(33). 29832–29839. 96 indexed citations
17.
Vieyra, Diego, et al.. (2000). A Panel of CAb Antibodies Recognize Endogenous and Ectopically Expressed ING1 Protein. Hybridoma. 19(2). 161–165. 23 indexed citations
18.
Loewith, Robbie, et al.. (2000). Three Yeast Proteins Related to the Human Candidate Tumor Suppressor p33 ING1 Are Associated with Histone Acetyltransferase Activities. Molecular and Cellular Biology. 20(11). 3807–3816. 136 indexed citations
19.
Riabowol, Karl, et al.. (2000). A Role for Serine Proteases in Mediating Phorbol Ester-Induced Differentiation of HL-60 Cells. Experimental Cell Research. 256(1). 264–271. 12 indexed citations
20.
Wong, Howard, et al.. (1998). Increased Expression of Cyclin D2 during Multiple States of Growth Arrest in Primary and Established Cells. Molecular and Cellular Biology. 18(6). 3163–3172. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026